| 產品名稱 |
Human rhinovirus 34 |
| 商品貨號 |
B203740 |
| Classification |
Picornaviridae, Rhinovirus, Human rhinovirus A |
| Deposited As |
Rhinovirus 34 |
| Agent |
Human rhinovirus 34 |
| Strain |
137-3 |
| Applications |
Respiratory research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Not listed in NIAID Catalog; presumed from human throat washing--see Special Characteristics |
| Product Format |
frozen |
| Storage Conditions |
-60°C |
| Comments |
VR-1365 was derived by passage of NIAID reagent V-114-003-021 (VR-1144) at the ATCC. CPE and virus titer develop best when infected cells are incubated on a roller apparatus or rocker plate. See also: Hamre D. et al., J. Lab. Clin. Med. 64:450, 1964. VR-1365 was derived by passage of NIAID reagent V-114-003-021 (VR-1144) at the ATCC. |
| Effect on Host |
Yes, in vitro effects: Cytopathic effects in tissue culture CPE |
| Recommended Host |
H1-HeLa cells (ATCC CRL-1958) Host of Choice: WI, HeLa, MRC-5 cells Host Range: HD, HEK, stable human cell cultures and also MkK cells for some strains HeLa cells (ATCC CCL-2); human diploid fibroblasts; human embryonic kidney cells; monkey kidney cells |
| Growth Conditions |
Max Temperature: 35.0°C Min Temperature: 33.0°C Duration: 3-5 days |
| Name of Depositor |
NIH/NIAID |
| Source |
Not listed in NIAID Catalog; presumed from human throat washing--see Special Characteristics |
